2016

UAsure is an easy and quick way (just three steps with results in thirty seconds!) to measure the level of uric acid in your blood at any given time.

We evaluated Galectin-3 (Gal-3) as a potential early biomarker of acute kidney disease (AKI), and the effect of Gal-3 inhibition by modified citrus pe…

We evaluated Galectin-3 (Gal-3) as a potential early biomarker of acute kidney disease (AKI), and the effect of Gal-3 inhibition by modified citrus pe…

Share your videos with friends, family, and the world

UAsure is an easy and quick way (just three steps with results in thirty seconds!) to measure the level of uric acid in your blood at any given time.

Dipyridamole is a drug in use for the past 55 years for treating heart conditions. In 2012 a breakthrough was reached when Moshe Rogosnitzky discovered that dipyridamole eye drops are effective in treating difficult eye conditions such as dry eye, pterygium, pinguecula, cataract, nevus and a variety of other eye disorders.

"Startpage.com - The world's most private search engine"

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative motor neuron disease accompanied by both systemic and central nervous system–specific…

Two forms of a peptide derived from a naturally-occurring human protein can force tumors to shrink significantly in an animal model of metastatic ovarian cancer, according to a team of researchers.

Two forms of a peptide derived from a naturally-occurring human protein can force tumors to shrink significantly in an animal model of metastatic ovarian cancer, according to a team of researchers.

Two forms of a peptide derived from a naturally-occurring human protein can force tumors to shrink significantly in an animal model of metastatic ovarian cancer, according to a team of researchers.

Two forms of a peptide derived from a naturally-occurring human protein can force tumors to shrink significantly in an animal model of metastatic ovarian cancer, according to a team of researchers.

Two forms of a peptide derived from a naturally-occurring human protein can force tumors to shrink significantly in an animal model of metastatic ovarian cancer, according to a team of researchers.

Two forms of a peptide derived from a naturally-occurring human protein can force tumors to shrink significantly in an animal model of metastatic ovarian cancer, according to a team of researchers.

After heart disease, cancer is the second leading cause of death worldwide. One in two men and one in three women will be diagnosed with some type of cancer in their lifetime. Despite novel initiative...